HELEN KATRINA TAYTON-MARTIN
CIK 1661780 · Chief Business & Strgy Officer · last filed 2024-01-17
HELEN KATRINA TAYTON-MARTIN is a Chief Business & Strgy Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for ADAP, was dated Jan 17, 2024. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
13
-$2.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Chief Business & Strgy Officer | 1,800,000 | $0.06 | $104.2K | -$2.20M | 9 | 2024-01-17 |
| ASND | Chief Business Officer | — | $218.06 | — | $0 | 3 | 2019-01-08 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-17 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-17 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-13 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-19 | — | Disp (D) | — | $0 | |
| 2021-03-03 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Exer (M) | +1,785,000 | $280.2K | EDGAR |
| 2021-01-11 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-04 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −200,000 | -$1.75M | EDGAR |
| 2020-01-17 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-15 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −100,000 | -$450.0K | EDGAR |
| 2019-01-08 | ASND | Grant (A) | — | $0 | EDGAR |